Clinical Trial Update: Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study [Phase 4]

View source ↗

Summary

Phase 4 trial update on sacubitril-valsartan (ENTRESTO) in chronic heart failure and sleep apnea syndrome is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Sleep Apnea Syndrome

Drugs mentioned

• Entresto (sacubitril/valsartan)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Chronic Heart Failure, Sleep Apnea Syndrome | Phase 4 | Status: COMPLETED